Responses
Extended reports
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
Compose a Response to This Article
Other responses
No responses have been published for this article.